Prognostic Significance of Pretreatment [ 18 F]ALF-NOTA-FAPI-04 PET/CT in Patients With Recurrent Gastric Cancer Undergoing Combined PD-1 Inhibitor and Chemotherapy

作者
Haifeng He,Yongzhi Xie,Chengzhi Jiang,Wanjing Zhou,Hui Ye
出处
期刊:Korean Journal of Radiology [Korean Society of Radiology]
卷期号:27 (3): 264-264 被引量:2
标识
DOI:10.3348/kjr.2025.1458
摘要

Objective: This study aimed to evaluate the prognostic value of [ 18 F]ALF-NOTA-FAPI-04 PET/CT-derived parameters, including the maximum standardized uptake value (SUVmax), FAPI-avid tumor volume (FTV), and total lesion FAP expression (TLF), in patients with recurrent gastric cancer undergoing combined chemoimmunotherapy.We sought to establish a noninvasive imaging biomarker framework to optimize patient stratification and therapeutic decision-making. Materials and Methods:This retrospective cohort study analyzed 51 patients with recurrent gastric cancer who received programmed cell death protein 1 (PD-1) inhibitors combined with chemotherapy after gastrectomy.All patients underwent [ 18 F]ALF-NOTA-FAPI-04 PET/CT within 14 days of chemoimmunotherapy.Semi-quantitative parameters (SUVmax, FTV, and TLF) were derived using semi-automated tumor segmentation.The primary endpoint of this study was the assessment of the clinical efficacy of chemoimmunotherapy, categorized as a durable or nondurable clinical benefit.The secondary endpoints included progression-free survival (PFS) and overall survival (OS).In a subgroup of 16 patients who underwent sequential [ 18 F]FDG PET/CT within seven days of [ 18 F]ALF-NOTA-FAPI-04 PET/CT, tracer uptake values were compared between the two PET/CT examinations.Results: 51 patients were included.The median PFS and OS were 7 and 10 months, respectively.Durable clinical benefit (DCB) was observed in 30 patients and showed significantly lower SUVmax, FTV, and TLF values than non-DCB.TLF demonstrated the highest diagnostic accuracy for DCB (area under the receiver operating characteristic curve [AUC] = 0.80).Multivariable analysis identified TLF ≥ 188.88 SUVbw•cm 3 as an independent factor associated with PFS (hazard ratio [HR] = 7.29, P = 0.001) and FTV ≥ 44.17 cm 3 as an independent factor associated with OS (HR = 5.16, P = 0.010).In the subgroup analysis of 16 patients, semi-quantitative analysis demonstrated consistently higher values of [ 18 F]ALF-NOTA-FAPI-04-derived parameters than [ 18 F]FDG-derived parameters (all P < 0.001).Conclusion: [ 18 F]ALF-NOTA-FAPI-04 PET/CT may be a useful imaging tool for predicting clinical outcomes in patients with recurrent gastric cancer undergoing treatment with PD-1 inhibitors and chemotherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Red发布了新的文献求助10
刚刚
嚣张贤王完成签到,获得积分10
刚刚
Yaon-Xu完成签到,获得积分10
刚刚
刚刚
英吉利25发布了新的文献求助10
刚刚
若晨完成签到,获得积分10
1秒前
akion完成签到,获得积分10
1秒前
lvh111完成签到,获得积分10
1秒前
沉默晓绿完成签到,获得积分10
1秒前
1秒前
耶耶耶完成签到,获得积分10
2秒前
dan完成签到 ,获得积分10
2秒前
白夜行完成签到,获得积分10
2秒前
未了发布了新的文献求助10
2秒前
包子完成签到,获得积分10
2秒前
星空发布了新的文献求助10
2秒前
文静的海完成签到,获得积分10
3秒前
QinCaibin完成签到,获得积分10
3秒前
3秒前
高木木完成签到,获得积分10
3秒前
重要莹发布了新的文献求助10
3秒前
lkp完成签到,获得积分10
3秒前
Jasper的应助被winnie你外卖到了采纳,获得10
4秒前
欣喜凌旋完成签到,获得积分10
4秒前
大方的曼容完成签到 ,获得积分10
4秒前
喝口可乐的应助被menghan采纳,获得10
5秒前
5秒前
独特的小吴完成签到 ,获得积分10
6秒前
关你什么柿完成签到,获得积分10
6秒前
zzt完成签到,获得积分10
6秒前
youshower完成签到 ,获得积分10
6秒前
lcy完成签到,获得积分10
6秒前
森林发布了新的文献求助10
6秒前
科研通AI65的应助被爱意随风起采纳,获得10
6秒前
Maestro_S的应助被lidinf采纳,获得10
7秒前
yzr01完成签到,获得积分10
7秒前
随风ALW完成签到,获得积分10
7秒前
CC66发布了新的文献求助10
7秒前
7秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180586
求助须知:如何正确求助?哪些是违规求助? 9570581
关于积分的说明 21813457
捐赠科研通 7776777
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557547
邀请新用户注册赠送积分活动 2479253